This is a position statement providing practical guidelines for neurologists on diagnosing and assessing fibromyalgia (FM), emphasizing the application of recent ACR criteria and the investigation of small-fiber involvement.
Neurological Sciences · 15 authors, 11 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This is a position statement providing practical guidelines for neurologists on diagnosing and assessing fibromyalgia (FM), emphasizing the application of recent ACR criteria and the investigation of small-fiber involvement.
This position statement offers a non-structured, expert-based review of recent literature to guide neurologists in the clinical and instrumental assessment of fibromyalgia. The authors recommend applying the 2016 ACR diagnostic criteria and state that a rheumatologic visit is mandatory. For evaluating small-fiber pathology, they suggest using at least two specific diagnostic tests, which may be followed by monitoring for underlying metabolic, immunological, or paraneoplastic conditions. The document highlights that a correct diagnostic approach can help exclude known causes of small-fiber impairment. Limitations noted include the non-systematic review method and a focus only on studies from the last 10 years. The authors conclude that clarifying the underlying mechanisms of FM will ultimately improve treatment.